NUTRISCLER: Assessment of Nutritional Status in Systemic Sclerosis

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Recruiting
CT.gov ID
NCT04301596
Collaborator
(none)
150
1
40
3.8

Study Details

Study Description

Brief Summary

The main theme of the cohort of systemic sclerosis (SSc) patients is the determination of nutritional status, its evolution and the evaluation of its management in patients with scleroderma.

The main objectives are :
  • To determine the incidence of malnutrition and its main determinants (disease characteristics, severity, eating habits, physical activity) in patients with scleroderma.

  • For patients with undernutrition at inclusion or at 18 months follow-up:

evaluate the impact of a standardized nutritional intervention (dietary advice, oral supplements, artificial, enteral or parenteral nutrition) on nutritional and disease parameters.

Follow-up visits will take place every 6 months for 2 years. (M6, M12, M18 et M24).

During each visit: a clinical examination, with anthropometric measurements, a 3-day dietary survey and a blood sample (10 ml), completion a multiple-choice of quality of life and physical activity evaluation.

Paraclinical evaluation : echocardiography, lung function tests, screening for osteoporosis (M6 and M18).

If undernutrition is detected during a follow-up visit, the subject will be referred to a specialized service.

Condition or Disease Intervention/Treatment Phase
  • Other: Collection of data

Study Design

Study Type:
Observational
Anticipated Enrollment :
150 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Assessment of Nutritional Status in Systemic Sclerosis: Prospective Cohort Study in Montpellier University Hospital
Actual Study Start Date :
Jun 12, 2020
Anticipated Primary Completion Date :
Jun 12, 2023
Anticipated Study Completion Date :
Oct 12, 2023

Arms and Interventions

Arm Intervention/Treatment
SSc patients

Other: Collection of data
different set of data will be collected over a 6 months period

Outcome Measures

Primary Outcome Measures

  1. Incidence of malnutrition [6 months]

    Incidence of malnutrition will be measured as a loss of more than 10% of body weight or a body mass index (BMI) less than 21 kg/m2

  2. Idetification of risk factors associated with malnutrition [6 months]

    Collection of data related to SSc disease burden

  3. Success of the nutritional intervention [6 months]

    body weight gain > 5%

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All SSc patients aged 18 or more

  • Patient followed at the Montpellier University Hospital

  • Patients must fulfil the American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR) 2013 criteria for SSc.

  • Health insurance (affiliation to social security)

  • Collection of non-opposition to participate in the study

Exclusion Criteria:
  • Patient under the protection of justice curatorship / guardianship;

  • Patients who have already planned to move out of the region in the next two years, making the follow-up impossible.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Montpellier University Hospital Montpellier France

Sponsors and Collaborators

  • University Hospital, Montpellier

Investigators

  • Principal Investigator: Alexandre MARIA, Montpellier University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Montpellier
ClinicalTrials.gov Identifier:
NCT04301596
Other Study ID Numbers:
  • RECHMPL19_0409
  • UF7840
First Posted:
Mar 10, 2020
Last Update Posted:
Sep 2, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 2, 2021